SmokingPhase 1WebQuitNCT01166334
WebQuit Online Smoking Cessation Study
A Phase 1 study testing WebQuit study group in people with Smoking, run by Fred Hutchinson Cancer Center at 1 site in United States.
Trial summary
Would you like to quit smoking? Seattle's Fred Hutchinson Cancer Research Center is launching a new study that may be able to help. Participants who enroll in this study will be randomly assigned by computer (like flipping a coin) to one of two online programs. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Smoking
- What is being tested?
- WebQuit study group
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 721 participants
- Where
- 1 siteUnited States
- Study dates
- Jun 2010to Jan 2012
- Phase
- Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- 18 or older
- a current resident of the US
- someone who has smoked daily for at least the past 12 months
- someone who wants to quit smoking in the next 30 days
- willing and able to read in English
- able to connect to the Internet for at least one hour per week for three consecutive months
Show all 10Show fewer
- able to use a website
- not participating in other smoking cessation interventions
- willing and able to complete a Baseline Survey
- willing to be randomized to either online program
Who cannot join
- inability to meet inclusion criteria
Trial locations and contacts
1 site in 1 country.
United States1 site
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109
About this study
Would you like to quit smoking?
Seattle's Fred Hutchinson Cancer Research Center is launching a new study that may be able to help. Participants who enroll in this study will be randomly assigned by computer (like flipping a coin) to one of two online programs. The goal of this study is to learn which of these programs is the most effective at helping people stop smoking. Findings from this study will be used to help build more effective online smoking cessation programs in the future.
Read more
Participants in both of the smoking cessation programs used in this study will receive:
- Interactive tools for dealing more effectively with urges to smoke
- Step-by-step guides for quitting smoking
- Personalized plans for quitting and remaining smoke-free
- Electronic links for reaching one-on-one expert help for quitting
Participants will be asked to complete online questionnaires, including a brief three-month follow-up survey.
There is no cost for participating in this study.
To enroll in this study or for more information, please visit www.webquit.com.
This study is being conducted by Seattle's Fred Hutchinson Cancer Research Center (www.fhcrc.org), a world leader in advancing the prevention, diagnosis and treatment of cancer. The principal investigator for the WebQuit smoking cessation study is Dr. Jonathan Bricker, a faculty member at both the Hutchinson Center and at the University of Washington in Seattle.
- Conditions
- Smoking
- Being tested
- WebQuit study group, WebQuit control group
- Keywords
- Smoking, Smoke, Cigarette, Cessation, Quit, Online, Web, Stop
- Medical subject headings
- Smoking
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
WebQuit study groupBehavioural
Description withheld to protect integrity of study
WebQuit control groupBehavioural
Identity and description withheld to protect integrity of study
| Study group | Role | What they receive |
|---|---|---|
| WebQuit study group | Active comparator | Intervention arm 1 (identity and description withheld to protect integrity of study) Receives: Behavioral: WebQuit study group |
| WebQuit control group | Active comparator | Intervention arm 2 (identity and description withheld to protect integrity of study) Receives: Behavioral: WebQuit control group |
What is being measured
The primary outcome is the main question the study is designed to answer.
7-day point prevalence
No smoking in the past 7 days, as reported 3 months post treatment.
Measured: 3 months and 6 months post treatment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Jul 2010 (estimated)
- Study startJun 2010
- Primary completionJan 2012
- Study completionJan 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for SmokingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 1
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 721 participants (actual)
Sponsor and investigators
- Lead sponsor
- Fred Hutchinson Cancer Center
- Sponsor type
- University, hospital or other
- Investigators
- Jonathan Bricker, PhD, Principal investigator, Fred Hutchinson Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01166334
- Sponsor's protocol ID
- FHCRC IR#7181
- Acronym
- WebQuit
- Status last verified
- Oct 2013
- First submitted
- 19 Jul 2010
- Last updated
- 11 Oct 2013
- Results posted
- No
- Data monitoring committee
- No
Publications
Kwon DM, Santiago-Torres M, Mull KE, Sullivan BM, Bricker JB. Older adults who smoke: Do they engage with and benefit from web-based smoking cessation interventions? Prev Med. 2022 Aug;161:107118. doi: 10.1016/j.ypmed.2022.107118. Epub 2022 Jun 17.
PubMed 35718119Jones HA, Heffner JL, Mercer L, Wyszynski CM, Vilardaga R, Bricker JB. Web-based acceptance and commitment therapy smoking cessation treatment for smokers with depressive symptoms. J Dual Diagn. 2015;11(1):56-62. doi: 10.1080/15504263.2014.992588.
PubMed 25671683
Study at a glance
From the registry record, last updated by the sponsor on 11 Oct 2013. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- WebQuit Online Smoking Cessation Study
- ClinicalTrials.gov ID
- NCT01166334
- Acronym / sponsor ID
- WebQuit / FHCRC IR#7181
- Conditions
- Smoking
- Keywords
- Smoking, Smoke, Cigarette, Cessation, Quit, Online, Web, Stop
- Phase
- Phase 1
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 721 participants (actual)
- Lead sponsor
- Fred Hutchinson Cancer CenterUniversity, hospital or other
- Study start
- Jun 2010
- Primary completion
- Jan 2012 (actual)
- Study completion
- Jan 2012 (actual)
- First posted
- 21 Jul 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Would you like to quit smoking?
Seattle's Fred Hutchinson Cancer Research Center is launching a new study that may be able to help. Participants who enroll in this study will be randomly assigned by computer (like flipping a coin) to one of two online programs. The goal of this study is to learn which of these programs is the most effective at helping people stop smoking. Findings from this study will be used to help build more effective online smoking cessation programs in the future.
Participants in both of the smoking cessation programs used in this study will receive:
- Interactive tools for dealing more effectively with urges to smoke
- Step-by-step guides for quitting smoking
- Personalized plans for quitting and remaining smoke-free
- Electronic links for reaching one-on-one expert help for quitting
Participants will be asked to complete online questionnaires, including a brief three-month follow-up survey.
There is no cost for participating in this study.
To enroll in this study or for more information, please visit www.webquit.com.
This study is being conducted by Seattle's Fred Hutchinson Cancer Research Center (www.fhcrc.org), a world leader in advancing the prevention, diagnosis and treatment of cancer. The principal investigator for the WebQuit smoking cessation study is Dr. Jonathan Bricker, a faculty member at both the Hutchinson Center and at the University of Washington in Seattle.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| WebQuit study group | Active comparator | Behavioral: WebQuit study groupIntervention arm 1 (identity and description withheld to protect integrity of study) |
| WebQuit control group | Active comparator | Behavioral: WebQuit control groupIntervention arm 2 (identity and description withheld to protect integrity of study) |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (10 listed)
- 18 or older
- a current resident of the US
- someone who has smoked daily for at least the past 12 months
- someone who wants to quit smoking in the next 30 days
- willing and able to read in English
Key exclusion criteria (1 listed)
- inability to meet inclusion criteria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| WebQuit study groupDescription withheld to protect integrity of study | Behavioural | WebQuit study group |
| WebQuit control groupIdentity and description withheld to protect integrity of study | Behavioural | WebQuit control group |
Primary outcome
7-day point prevalence
Time frame: 3 months and 6 months post treatment
No smoking in the past 7 days, as reported 3 months post treatment.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Oct 2013.
- Derived from this study: PubMed 35718119Kwon DM, Santiago-Torres M, Mull KE, Sullivan BM, Bricker JB. Older adults who smoke: Do they engage with and benefit from web-based smoking cessation interventions? Prev Med. 2022 Aug;161:107118. doi: 10.1016/j.ypmed.2022.107118. Epub 2022 Jun 17.
- Derived from this study: PubMed 25671683Jones HA, Heffner JL, Mercer L, Wyszynski CM, Vilardaga R, Bricker JB. Web-based acceptance and commitment therapy smoking cessation treatment for smokers with depressive symptoms. J Dual Diagn. 2015;11(1):56-62. doi: 10.1080/15504263.2014.992588.
Related trials for Smoking
Active, not recruiting
An Interactive Smartphone Application to Motivate Smokers to Quit
Smoking Cessation, Smoking Behaviors
Not yet recruiting
Impact of Multidisciplinary Care, Structured and Targeted on the COPD Patient's Clinical Pathway.
Chronic Obstructive Pulmonary Disease, Lung Diseases, Obstructive
Not yet recruiting
Comparing the Efficacy of a Conversational Agent (QuitBot) Versus Standard Health Education on Smoking Cessation Among Medical Students; A Randomized Controlled Trial.
Conversational Agent, Smoking Cessation
Enrolling by invitationObservational study
Using Smartwatches to Monitor Smoking in Real-life Situations
Smoking
Active, not recruitingPhase 3
Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
Tobacco Dependence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jonathan Bricker, PhD principal investigator
Fred Hutchinson Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 1 study testing WebQuit study group in people with Smoking, run by Fred Hutchinson Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Oct 2013. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
7-day point prevalence (time frame: 3 months and 6 months post treatment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01166334, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Oct 2013.